The Gladstone Institutes are an independent and nonprofit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as
heart failure,
HIV/AIDS and
Alzheimer's disease. Gladstone researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the breakthrough development of
induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate
Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.